These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3290017)

  • 1. Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes.
    Kolb H; Dannehl K; Grüneklee D; Zielasek J; Bertrams J; Hübinger A; Gries FA
    Diabetologia; 1988 Apr; 31(4):189-94. PubMed ID: 3290017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
    Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
    Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
    Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
    Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children.
    Lernmark A; Hägglöf B; Freedman Z; Irvine J; Ludvigsson J; Holmgren G
    Diabetologia; 1981 Apr; 20(4):471-4. PubMed ID: 7016642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cell antibodies in normal French schoolchildren.
    Lévy-Marchal C; Tichet J; Fajardy I; Gu XF; Dubois F; Czernichow P
    Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
    Tun RY; Peakman M; Alviggi L; Hussain MJ; Lo SS; Shattock M; Pyke DA; Bottazzo GF; Vergani D; Leslie RD
    BMJ; 1994 Apr; 308(6936):1063-8. PubMed ID: 8173426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
    Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
    Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-islet autoantibodies detected by monoclonal antibody 1A2: further studies suggesting a role in the pathogenesis of IDDM.
    McEvoy RC; Thomas NM; Greig F; Larson S; Vargas-Rodriguez I; Felix I; Wallach E; Rubinstein P; Goetz FC; Ginsberg-Fellner F
    Diabetologia; 1996 Nov; 39(11):1365-71. PubMed ID: 8933006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
    Vandewalle CL; Decraene T; Schuit FC; De Leeuw IH; Pipeleers DG; Gorus FK
    Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.
    Bruining GJ; Molenaar J; Tuk CW; Lindeman J; Bruining HA; Marner B
    Diabetologia; 1984 Jan; 26(1):24-9. PubMed ID: 6368297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
    Mustonen A; Knip M; Akerblom HK
    Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study.
    Levy-Marchal C; Czernichow P
    Diabete Metab; 1993; 19(3):296-303. PubMed ID: 8405620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.